Ongoing measles transmission, fueled by large outbreaks in Pennsylvania and Ohio, is driving rapid case growth and shaping near-term trader expectations for the U.S. total by August 31. As of August 20, the CDC reported 2,777 confirmed 2026 cases across 47 jurisdictions, with 94% outbreak-associated and 93-94% occurring in unvaccinated or unknown-status individuals; the most recent weekly update added 211 cases, more than double prior increments. High transmissibility via respiratory droplets, combined with 19% of cases in children under 5 and school reopenings, supports continued acceleration through late August. CDC surveillance updates and state health department reports in the coming week represent key data points that could shift market-implied odds, though models note variability in reporting lags and under-ascertainment.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoMeasles cases in U.S. by August 31?
Measles cases in U.S. by August 31?
NOWE
Aug 31, 2026
2800+
87%
2825+
83%
2850+
74%
$592 Wol.
2800+
$217 Wol.
87%
2825+
$200 Wol.
83%
2850+
$175 Wol.
74%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission, fueled by large outbreaks in Pennsylvania and Ohio, is driving rapid case growth and shaping near-term trader expectations for the U.S. total by August 31. As of August 20, the CDC reported 2,777 confirmed 2026 cases across 47 jurisdictions, with 94% outbreak-associated and 93-94% occurring in unvaccinated or unknown-status individuals; the most recent weekly update added 211 cases, more than double prior increments. High transmissibility via respiratory droplets, combined with 19% of cases in children under 5 and school reopenings, supports continued acceleration through late August. CDC surveillance updates and state health department reports in the coming week represent key data points that could shift market-implied odds, though models note variability in reporting lags and under-ascertainment.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Aug 24, 2026, 10:08 AM ET
Wolumen
$592Data zakończenia
Aug 31, 2026Rynek otwarty
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission, fueled by large outbreaks in Pennsylvania and Ohio, is driving rapid case growth and shaping near-term trader expectations for the U.S. total by August 31. As of August 20, the CDC reported 2,777 confirmed 2026 cases across 47 jurisdictions, with 94% outbreak-associated and 93-94% occurring in unvaccinated or unknown-status individuals; the most recent weekly update added 211 cases, more than double prior increments. High transmissibility via respiratory droplets, combined with 19% of cases in children under 5 and school reopenings, supports continued acceleration through late August. CDC surveillance updates and state health department reports in the coming week represent key data points that could shift market-implied odds, though models note variability in reporting lags and under-ascertainment.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$592Data zakończenia
Aug 31, 2026Rynek otwarty
Aug 24, 2026, 10:08 AM ETResolver
0x65070BE91...Ongoing measles transmission, fueled by large outbreaks in Pennsylvania and Ohio, is driving rapid case growth and shaping near-term trader expectations for the U.S. total by August 31. As of August 20, the CDC reported 2,777 confirmed 2026 cases across 47 jurisdictions, with 94% outbreak-associated and 93-94% occurring in unvaccinated or unknown-status individuals; the most recent weekly update added 211 cases, more than double prior increments. High transmissibility via respiratory droplets, combined with 19% of cases in children under 5 and school reopenings, supports continued acceleration through late August. CDC surveillance updates and state health department reports in the coming week represent key data points that could shift market-implied odds, though models note variability in reporting lags and under-ascertainment.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania